Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Human trials initiated for IL-13 cytotoxin under development by NeoPharm

Oct. 20, 1999

AltaRex reports new partnering plans for OvaRex MAb

Oct. 19, 1999

ImmunoGen presents positive pharmacokinetic data for huC242-DM1/SB-408075

Oct. 19, 1999

Neurocrine Biosciences' NBI-3001 granted fast track designation

Oct. 18, 1999

Immune Response reports data from phase I colon cancer vaccine study

Oct. 18, 1999

Endorex study shows immune response stimulation by ImmTher in human cancer cells

Oct. 18, 1999

Antimetastatic activity demonstrated for new MAb in breast cancer-bearing mice

Oct. 13, 1999

Full enrollment reached in phase III trial of GMK cancer vaccine

Oct. 12, 1999

Phase I/II results support further development of Leuvectin

Oct. 8, 1999

NCI supports clinical development of StressGen's lead product

Oct. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...